Content generated by AI editorial engine. Editorially supervised by Sedat ANAK.
The median of 4 price targets is $300[FMP target], stock is $254, +18.1% vs the analyst consensus median. Q1 FY26 EPS $4.25 vs $4.09 estimate: beat (+3.9%)[FMP earnings]. Stock move on D+1: -0.4%.
B+ — FMP rating [FMP ratings]. Form 4: unavailable[FMP Form 4].
Quick AnswerLabcorp Holdings Inc. (LH) Q2 consensus: revenue $3.7B[FMP est], EPS $4.78[FMP est]. 8 consecutive quarters of beat[FMP earnings].
Q1 FY26 EPS $4.25 vs $4.09 estimate: beat (+3.9%)[FMP]. Stock move on D+1: -0.4%[FMP D+1].
Watchlist
Biopharma Growth
biopharma_growth
Biopharma Laboratory Services (BLS) revenue grew by 8.2%, with central labs driving the growth.
"Biopharma Laboratory Services revenue grew to $781 million, up 8.2% compared to last year, which includes a 5.5% benefit from foreign currency translation."
- Julia Wang, CFO - Q1 FY26 Earnings Call - April 30, 2026
Revenue Growth
revenue_growth
Labcorp had a strong start to the year, achieving a revenue increase of 5.8% in the first quarter.
"In the first quarter, enterprise revenue grew 5.8% and enterprise adjusted operating margin expanded more than 30 basis points to 14.4%."
- Julia Wang, CFO - Q1 FY26 Earnings Call - April 30, 2026
Fy26 Guidance Increase
fy26_guidance_increase
Labcorp is raising its revenue and earnings per share (EPS) expectations for 2026.
"We are raising the midpoint of the enterprise revenue range by approximately $30 million and the midpoint of the EPS range by $0.13."
- Julia Wang, CFO - Q1 FY26 Earnings Call - April 30, 2026
Diagnostics Growth
diagnostics_growth
Diagnostic Laboratories delivered another strong quarter with 5% revenue growth.
"Diagnostic Laboratories delivered another strong quarter with 5% revenue growth to $2.8 billion."
- Julia Wang, CFO - Q1 FY26 Earnings Call - April 30, 2026
Bls Backlog
bls_backlog
The BLS segment ended the quarter with a backlog of $8.6 billion, and we expect approximately $2.7 billion to convert into revenue over the next 12 months.
"Our BLS segment ended the quarter with a backlog of $8.6 billion, and we expect approximately $2.7 billion to convert into revenue over the next 12 months."
- Julia Wang, CFO - Q1 FY26 Earnings Call - April 30, 2026
Stock Expert AI - Methodology
Historical V1 earnings-model score (archived, May 9, 2026) — not the current MoonshotScore. Current MoonshotScore: LH stock page
multi-pillar methodology. News Sentiment strong. Revenue Growth weak.
How is it calculated? ->6 investor frameworks. 2 bullish (Ray Dalio, Buffett), 1 bearish (Ken Griffin), 3 neutral (Jim Simons, Klarman, Munger).
How is it calculated? ->Quality business, trading at fair value.
How is it calculated? ->Past Performance
Q1 FY26 (April 30, 2026) EPS $4.25 vs $4.09 estimate: beat (+3.9%)[FMP]. Stock move on D+1: -0.4%[FMP D+1].
Q1 FY26 EPS $4.25 vs $4.09 estimate: beat (+3.9%)[FMP]. Stock move on D+1: -0.4%[FMP].
No RPO/backlog concentration disclosed in Q1 earnings call.
Q1 CapEx $121.0M[FMP cashflow]. Q1 op margin 10.9%[FMP op margin] - this level in Q4 is sensitive to CapEx revision risk.
Not advice - a structural framework for earnings night. Decision discipline is yours.
Market Outlook
You read it in 5 minutes. When the numbers come out on Thursday evening - you know what you're looking at.
Data arrives at night. The framework is ready now.
Data arrives on Thursday evening. The framework is ready on this page: Q2 EPS threshold $4.78[FMP], CapEx threshold "below $121.0M". Two anchors, three scenarios.
Comparison Stock Expert AI is free today — no credit card.
Seeking Alpha $299/yr - analyst opinions + earnings coverage TipRanks $360/yr - Smart Score (1-10) + analyst consensus + insider trades Trendspider $400/yr - AI pattern detection + automated TA + multi-timeframe alerts
Prices as of April 2026. Sources: seekingalpha.com/subscriptions - tipranks.com/pricing - trendspider.com/pricing
Stock Expert AI is free today — no credit card. Council 7-lens analysis + MoonshotScore multi-pillar + Insider tracker + Technical levels - all in one platform, for every stock.
Educational tool, not investment advice. Past performance does not guarantee future results.
Calendar
DATA GAP: Events not in the FMP /stable/calendar feed - Investor day, analyst day, product launches, regulatory dates. These require company IR page scraping or manual calendar entry.
This Labcorp Holdings Inc. (LH) Q2 FY26 earnings preview covers the analyst consensus, key catalysts, and what to watch on the earnings call.
Labcorp Holdings Inc. (LH): Consensus EPS, revenue guidance, segment growth rates, and the tone of management commentary — the full breakdown with sources is on this page.
Labcorp Holdings Inc. (LH): Figures are sourced from Financial Modeling Prep (FMP) fundamentals and consensus data plus official earnings-call transcripts; derived metrics are labeled with their source next to each figure.
Labcorp Holdings Inc. (LH): No. This page is educational research, not investment advice. It summarizes analyst consensus and company data; consult a licensed financial advisor before making any investment decision.